Skip to content

VCEL

Vericel Corporation

NASDAQ · Healthcare · Biotechnology · US

$40.19
−0.69%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue306.3M276.3M237.2M197.5M164.4M
Cost of Revenue77.9M70.7M65.1M61.9M54.6M
Gross Profit228.4M205.6M172.1M135.6M109.8M
Operating Expenses
R&D Expense29.2M27.6M24.8M21.0M19.9M
SG&A Expense181.0M167.0M142.8M121.0M106.9M
General & Admin Expense
Selling & Marketing Expense
Other Expenses
Total Operating Expenses210.1M194.6M167.6M142.0M126.8M
Cost and Expenses288.1M265.2M232.7M204.0M181.4M
Operating Income (EBIT)18.2M11.0M4.5M(6.5M)(17.1M)
Non-Operating
Interest Income7.5M7.0M6.4M4.6M1.3M
Interest Expense640.0K1.6M614.0K600.0K366.0K
Net Interest Income6.9M5.5M5.8M4.0M975.0K
Other Non-Op Income/Expense6.8M6.3M6.0M4.1M1.1M
Non-Operating Income (excl Interest)(7.5M)(7.9M)(6.6M)(4.7M)(1.4M)
EBT (Pre-Tax Income)25.1M17.4M10.5M(2.4M)(16.0M)
Income Tax Expense859.0K859.0K148.0K814.0K721.0K
Bottom Line
Net Income24.2M16.5M10.4M(3.2M)(16.7M)
Earnings from Cont. Ops24.2M16.5M10.4M(3.2M)(16.7M)
Earnings from Discont. Ops
Bottom Line Net Income24.2M16.5M10.4M(3.2M)(16.7M)
Per Share
Basic EPS$0.48$0.33$0.21($0.07)($0.35)
Diluted EPS$0.47$0.32$0.20($0.07)($0.35)
Revenue Per Share$6.01$5.46$4.86$4.15$3.49
Shares
Basic Shares Outstanding50.9M50.6M48.8M47.6M47.1M
Diluted Shares Outstanding50.9M52.1M51.7M47.6M47.1M
Profitability Metrics
EBITDA38.5M30.3M16.6M2.9M(11.6M)
D&A12.7M11.4M5.5M4.6M4.0M
EBIT25.7M18.9M11.1M(1.8M)(15.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026